アメリカ合州国の2010年第35週08月29日ー09月04日の肺炎·風邪(インフルエンザ)感染死者は、609。

> Centers for Disease Control and Prevention (http://www.cdc.gov/)
Publications
> Morbidity and Mortality Weekly Report (MMWR)
Child Immunization Schedules
Jasnuary 8, 2010 / Vol. 58 / no.51 & 52
Recommended Immunization Schedules for Persons Aged 0 through 18 years - United States, 2010
· Adult Immunization Schedule
January 15, 2010 / Vol. 59 / No.
Recommended Adult Immunization Schedules - United States, 2010
MMWR Home
Publications
> Weekly Report
Morbidity and Mortality weekly report (MMWR)
MMWR Weekly : Current Volume (2919)
September 10, 2010 / Vol.59 / No.35 / Pg. 1125 - 1164
> · Notifiable Diseases and Mortality Tables
Weekly
September 10, 2010 / 59(35); 1149-1167
> Table III Deaths in 122 U.S-cities, weekending(August 29-)September 4, 2010 (35th week)
Pneumonia and Influenza total deaths is 609.

2010年09月10日金曜日09:25 曇り/晴れ 最低気温;18ºC 最高気温;29ºC BARCELONA県から
アメリカ合州国の2010年第35週08月29日ー09月04日の肺炎·風邪(インフルエンザ)感染死者は、609。このうち、新型インフルエンザ(ブタ風邪)は、ほとんどの99%。新型インフルエンザの始まった2009年04月25日から2010年09月04日までの、肺炎·風邪(インフルエンザ)感染死者の合計は、5万4979人(54'979)です。このうち、新型インフルエンザ(ブタ風邪)の感染死者は、最低 95% だから、ブタ風邪感染死者は、だいたい 5万2000人(52'000)くらいには、なるだろう。新型インフルエンザ(ブタ風邪)の感染速度(感染力)がほかの季節風邪(インフルエンザ)より、やく4倍なのに、そんなに、風邪感染死者が倍増しないのは、65歳くらいの老人には、ブタ風邪に対する免疫があって、多くの感染者は、若い世代に多く見られるから。ふつうの季節風邪(インフルエンザ)の感染死者のやく90%以上は、65歳以上の老人だから。抵抗力の貧弱な65歳以上の老人が、免疫があるので、感染力が4倍でも、若い世代の抵抗力は、強力なので、新型インフルエンザ(ブタ風邪)感染死者は、普通の季節風邪と同じくらいに留まっている。[ Updateinfluenzactivitis in U.U. 10th season (2009/08/30-2010/06/12)
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5929a2.htm?s_cid=mm5929a2_w]
オーストラリアでは、1回注射の6カ月以上の幼児の季節風邪予防注射のH1N1 PANVAX JUNIORは、有効期限が。1年から6カ月に縮小されて、現在の在庫の予防接種は、無効(効かない)ので、多重回注射の注射に切り替えた。また5歳以下の幼児用の予防注射(CSL製薬会社のFLU VAX)に、高熱や、発作的な発熱が起きている副作用が出ているので、現在 オーストラリアでは、用心のために、幼児への季節風邪の予防注射を中止している。風邪(インフルエンザ)にかかると重症に陥る既成症状のある患者は、副作用の危険性と、秤(はかり)にかけてみて、もし、5歳以下の幼児に季節風邪予防注射をする場合には、予防接種のVAXGRIP か、INFLUVAC を接種するように勧めている。
[http://www.healthemergency.gov.au/internet/healthemergency/publishing.nsf/Content/health-awine_influenza-index.htm]

Australian Government
Department of Health and Aging
LATEST NEWS
30 JULY 2010
Seasonal flu vaccination for youg children can be resumed -
Updated advice from the Chief Medical Officer

Departmental Media Releases

Seasonal flu vaccination for young children can be resumed - Updated advice from the Chief Medical Officer
Continued close monitoring of side effects with this year's seasonal flu vaccine in children under five years of age has shown that the higher than usual occurrence of fever and febrile convulsions appears to be confined to the vaccine Fluvax, manufactured by CSL so parents can now seek advice from their doctor to use other brands on the market if they want their young children vaccinated.

In this section:
Departmental Media Releases
Seasonal Flu Vaccine and young children
Australia and New Zealand Food Regulation Ministerial Council Final Communiqué
Australian Health Ministers’ Conference Communique
CMO To Step Down
Design of New National Registration and Accreditation Scheme
Dr Mukesh Haikerwal
Food Ministers Agree To A Strategic Vision For Australian And New Zealand Food Regulation System
Food Ministers Consider Food Labelling Review
Government on Track to Close the Gap on Infant Mortality
GPs are major players in H1N1 Influenza 09
Health authorities continue to put seasonal flu vaccine on hold for young children
Indigenous Australians recognised in H1N1 Influenza 09 Health Response
Joint Communiqué - Gene Technology Ministerial Council
National Medical Director of Organ and Tissue Donation and Transplantation Authority Appointed
New Commonwealth Chief Nurse Appointed
On Target to Halve the Gap in Indigenous Child Mortality
PBS listing to help prevent invasive fungal infections
Preventative Health Taskforce - Media Release
Prominent cancer specialist appointed new Commonwealth Chief Medical Officer
Prudent measures to conserve anti-coagulant medicines
Seasonal flu vaccination for young children can be resumed - Updated advice from the Chief Medical Officer
Seasonal Flu Vaccine Remains Suspended for young children without risk factors - Advice from the Chief Medical Officer
Self-Test Bowel Cancer Kits – Important Notice for Users
Serious adverse events identified in Queensland with the use of Peripherally Inserted Central Catheters (PICC lines)
Talk, tell, transform lives - Australians urged to make a new kind of New Year’s resolution in 2009
view more in this section
view less in this sectionPDF printable version of Seasonal flu vaccination for young children can be resumed - Updated advice from the Chief Medical Officer (PDF 57 KB)

30 July 2010

Continued close monitoring of side effects with this year's seasonal flu vaccine in children under five years of age has shown that the higher than usual occurrence of fever and febrile convulsions appears to be confined to the vaccine Fluvax, manufactured by CSL.

In my last report to parents and the medical profession on June 1 this year, I highlighted that Fluvax appeared to be the main concern but that, because of limited use there was insufficient evidence about the extent of fever and febrile convulsions associated with the other vaccines on the market.

I therefore continued to recommend the suspension of use of all seasonal flu vaccinations for healthy children under 5 years of age. At the same time I also encouraged parents to speak with their doctor about vaccination if a child had an underlying medical condition where flu could be harmful to the child and to carefully weigh the risks and benefits of vaccination in each individual child.

Since that announcement continued investigations in Australia and overseas indicate that there does not appear to be the higher than normal incidence of febrile convulsions in children under five with the other seasonal flu vaccines Influvac and Vaxigrip.

In particular, data from Australia and New Zealand show that rates of fever and febrile convulsions associated with Vaxigrip and Influvac are similar to those seen with trivalent seasonal flu vaccine in previous years.

While to date it has still not been possible to identify a biological or other basis that would explain the higher than expected observed rates of fever and febrile convulsions with Fluvax, the investigations are continuing.

In the meantime I am now advising that if parents of children under five years of age wish to have their children vaccinated against seasonal flu that they should discuss with their GP or vaccine provider the use of Vaxigrip or Influvac.

It should be noted that influenza itself often causes fever in young children which can lead to febrile convulsions and that all flu vaccines can cause this side effect which, if handled properly, is usually short lived. I am writing to all GPs and immunisation providers to advise them of my latest advice and to ask doctors to explain to parents what to do if fever occurs following vaccination.

More information is available on the Immunise Australia Hotline at 1800 671 811.

Media contact: Kay McNiece, 0412 132 585